372 related articles for article (PubMed ID: 31016626)
1. Current and Future Treatment of Helicobacter pylori Infections.
Matsumoto H; Shiotani A; Graham DY
Adv Exp Med Biol; 2019; 1149():211-225. PubMed ID: 31016626
[TBL] [Abstract][Full Text] [Related]
2. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
3. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
Fallone CA; Moss SF; Malfertheiner P
Gastroenterology; 2019 Jul; 157(1):44-53. PubMed ID: 30998990
[TBL] [Abstract][Full Text] [Related]
4. Development of
Suzuki S; Esaki M; Kusano C; Ikehara H; Gotoda T
World J Gastroenterol; 2019 Apr; 25(16):1907-1912. PubMed ID: 31086459
[No Abstract] [Full Text] [Related]
5. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S
Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022
[TBL] [Abstract][Full Text] [Related]
6. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.
Miftahussurur M; Yamaoka Y
Molecules; 2015 Apr; 20(4):6068-92. PubMed ID: 25856059
[TBL] [Abstract][Full Text] [Related]
7. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
Graham DY; Dore MP; Lu H
Expert Rev Anti Infect Ther; 2018 Sep; 16(9):679-687. PubMed ID: 30102559
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.
Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O
BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211
[TBL] [Abstract][Full Text] [Related]
9. Practical Aspects in Choosing a Helicobacter pylori Therapy.
Molina-Infante J; Shiotani A
Gastroenterol Clin North Am; 2015 Sep; 44(3):519-35. PubMed ID: 26314666
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive molecular analysis of
Ierardi E; Giorgio F; Iannone A; Losurdo G; Principi M; Barone M; Pisani A; Di Leo A
World J Gastroenterol; 2017 Apr; 23(14):2453-2458. PubMed ID: 28465629
[TBL] [Abstract][Full Text] [Related]
11. Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.
Papastergiou V; Georgopoulos SD; Karatapanis S
Curr Pharm Des; 2014; 20(28):4521-32. PubMed ID: 24180408
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.
Georgopoulos SD; Papastergiou V; Karatapanis S
Expert Opin Pharmacother; 2015; 16(15):2307-17. PubMed ID: 26330278
[TBL] [Abstract][Full Text] [Related]
15. Toward population specific and personalized treatment of Helicobacter pylori infection.
Liou JM; Chen PY; Kuo YT; Wu MS;
J Biomed Sci; 2018 Oct; 25(1):70. PubMed ID: 30285834
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Helicobacter pylori.
Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
[TBL] [Abstract][Full Text] [Related]
17. Practical treatment of Helicobacter pylori: a balanced view in changing times.
Smith SM; Haider RB; O'Connor H; McNamara D; O'Morain C
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):819-25. PubMed ID: 24892516
[TBL] [Abstract][Full Text] [Related]
18. Second-line rescue treatment of
Lin TF; Hsu PI
World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
[TBL] [Abstract][Full Text] [Related]
19. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Helicobacter pylori infection 2010.
O'Connor A; Gisbert JP; McNamara D; O'Morain C
Helicobacter; 2010 Sep; 15 Suppl 1():46-52. PubMed ID: 21054653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
